NCT07070310 (DeliVeriNN) is a clinical trial in Neurological Conditions, sponsored by Heart Centre Rotenburg.

Who is sponsoring NCT07070310?

NCT07070310 is sponsored by Heart Centre Rotenburg.

What condition does NCT07070310 study?

NCT07070310 studies Neurological Conditions.

Is NCT07070310 still recruiting?

NCT07070310 is currently not yet recruiting. Last updated 22 July 2025.

Last reviewed 2025-07-22 · How we verify

NCT07070310: DeliVeriNN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DELirium, Incidence, preVEntion and pRogression During Acute Intensive Neurological -Neurosurgical Rehabilitation

Not yet recruiting Last updated 22 July 2025

What this trial tests

trial in Neurological Conditions in 210 participants. Not yet recruiting.

Timeline

15 August 2025

Primary endpoint
15 August 2028

15 February 2029

Quick facts

Lead sponsor	Heart Centre Rotenburg
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	210
Start date	15 August 2025
Primary completion	15 August 2028
Estimated completion	15 February 2029
Sites	1 location across Germany

Conditions studied

Neurological Conditions — all drugs for Neurological Conditions →

Sponsor

Heart Centre Rotenburg

Who can join

18 and older, any sex, with Neurological Conditions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this longitudinal cohort study the incidence of delirium is assessed for all patients being admitted to the acute intensive neurological-neurosurgical rehabilitation over 3 years. Delirium assessment will be performed daily from admission to discharge. Patients will be divided into 3 groups, according to the presentation of delirium on admission, during the course or not any during the stay in acute rehabilitation and compared regarding the treatment and outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurological Conditions

Currently open trials in the same condition.

NCT06773169 — IAMABLE: Implementation and Evaluation of an App for Evidence-Based Self-Management Rehabilitation Strategies · NA · recruiting
NCT05443100 — Impact of WBC on Patients With Metabolic or Neurological Diseases or Fibromyalgia (WBC-MeNeFi) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07070310 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Heart Centre Rotenburg
Last refreshed: 22 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07070310.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing